Clinical-epidemiological Characterization of Patients with Chronic Actinic Damage in Las Tunas Province

Authors

Keywords:

radiation, actinic damage, photodamage, melasma, lentigo.

Abstract

Introduction: Chronic actinic damage is a group of alterations in the structure, function and appearance of the skin as a result of prolonged and uncontrolled exposure to ultraviolet radiation, other radiation and the use of inadequate sun protection, which can lead to skin carcinomas.

Objective: To characterize patients with chronic actinic damage seen in Dermatology consultation in the province of Las Tunas.

Methods: A descriptive, cross-sectional, observational study was carried out in a sample of 1720 patients diagnosed with chronic actinic damage, in the period from December 2019 to June 2020. The variables age, gender, skin color, skin phototype, occupation, use of sunscreen and sunscreen according to skin type, exposure to radiation and clinical characteristics of photodamage lesions were evaluated. The information obtained was presented in tables and statistical graphs and for the description the variables are shown in percentages.

Results: The predominance of the age group 25-59 years (70.9%) without significant influence of gender, higher incidence of white skin color (98.8%), skin phototype II (64.1%) and government workers (65.1%). A 74.8% of the patients frequently use some type of sun protection, 25.2% do not use it. 99.8% were not exposed to other types of radiation. Photodamage lesions were actinic keratoses (71.2%) and solar lentigo (7.3%).

Conclusions: The predominant clinical manifestation of photodamage was actinic keratosis. Most of the patients did not use sunscreen and those who did, did not use it according to their skin type or recommended frequency. Most of the population studied reported using at least some type of protection.

Author Biography

Katiuska Tamayo Mariño, Universidad de Ciencias Médicas Las Tunas

Especialista de Primer Grado en Dermatología. Diplomado en Medicina Natural y Tradicional. Miembro Numerario Capitulo Dermatología Las Tunas. Profesora Asistente

References

1. Bernabéu A. La necesaria fotoprotección. Farmacéutica [serial on the Internet]. 2007; 26(5): Available from: https://www.elsevier.es/es-revista-offarm-4-pdf-13102414.

2. Latina P. Una forma de vitamina B3 reduce el riesgo de cáncer de piel. Boletin de Prensa Al Día [serial on the Internet]. 2015 julio 23, 2020]: Available from: https://boletinaldia.sld.cu/aldia/2015/05/15/una-forma-de-vitamina-b3-reduce-el-riesgo-de-cancer-de-piel/.

3. Puericultura CRNd. Estrategia para la atención de niños y adolescentes con Daño Actínico Crónico. Cuba. 2008.

4. James E. Fitzpatrick WAHyWLK. Lesiones papulares escamosas. In: editors D, editor. Urgencias dermatológicas Diagnóstico Sintomático. Barcelona: Elsevier Inc.; 2018. p. 97.

5. James WDE, Dirk M.; Treat, James R.; Rosenbach, Misha A.; Neuhaus, Isaac M. Dermatoses Resulting From Physical Factors. Andrews' Diseases of the Skin, . 13th ed: Elsevier Inc.; 2019.

6. Russo Sea. Summer sun-exposure in Australian childhood cancer survivors and community reference groups. Semin Oncol. 2020 Feb 22.

7. Francisco González DAP, Jatziri Mireille Chávez Bernal et al. Terapia fotodinámica con luz de día en el tratamiento de la queratosis actínica y el campo de cancerización: recomendaciones de consenso para América Latina. Piel. 2017;32 (3):142-9.

8. FitzPatrick A. Atlas de Dermatologia Clinica. 7th ed. Dusseldorf2013.

9. Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. 2017 Aug;177(2):350-8.

10. Arenas GR. Atlas Dermatología. Diagnóstico y Tratamiento. 3ra ed: McGrawHill.

11. Mascaró JM. Pautas de diagnóstico y terapéutica en Dermatología. De la A a la Z. LEN/Mayo International SA, editor. España: Grupo Mayo; 2008.

12. al FCe. Precáncer cutáneo. Actas Dermosifiliográficas [serial on the Internet]. 2017; 108(1).

13. Sardá SP. Tratamiento de las queratosis actínicas. Piel. 2015;30:378-86.

14. Vila-Payeras ea. Evaluación de la tasa de detección incidental de cáncer cutáneo: estudio prospectivo en un servicio hospitalario. Actas Dermosifiliográficas [serial on the Internet]. 2020: Available from: www.actasdermo.org

15. Millan-Cayetano JFdT-M, Magdalena ¿Cómo debe realizarse el seguimiento de los pacientes tratados con vemurafenib? Piel. 2017;32:123-5

16. Manzur J. Dermatologia. La Habana: Ciencias Médicas; 2002.

17. Rafael Carmena Ramóna SS-A, Sofía Lucas-Truyolsa. Queratosis actínica:nuevo concepto y actualización terapéutica Atención Primaria. 2017 Oct, 2017;49(8):492-7.

18. L. Schneller-Pavelescu EV-dCyMMB. Erupción papulosa fotodistribuida. Actas Dermosifiliográficas. 2019;110(4):309---10.

19. Sánchez G NJ, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database of Systematic Reviews [serial on the Internet]. 2016; (7).

20. Marzo-Castillejo Mea. Recomendaciones de prevención del cáncer. Actualización PAPPS 2018 2018 May, 2018;50:41-65.

21. González MER. Atribuyen al café una función protectora frente al melanoma. Boletín Al Día [serial on the Internet]. 2015: Available from: https://boletinaldia.sld.cu/aldia/2015/04/14/atribuyen-al-cafe-una-funcion-protectora-frente-al-melanoma.

22. Luis Requena CRyCJC. Proliferaciones y tumores epidérmicos benignos. In: Elsevier, editor. Dermatología. 4th ed. España: Elsevier; 2019. p. 1894-916.

23. Martinez-Leborans Lea. Extrafacial Lentigo Maligna: A Report on 14 Cases and a Review of the Literature. Actas Dermosifiliogr. 2016 Oct;107(8):e57-63.

24. Ferrándiz C MJ, Guillén C, Ferrándiz-Pulido C, Fernández-Figueras MT Precancerous Skin Lesions. Actas dermosifiliográficas. 2017;108:31-41.

Published

2022-11-18

How to Cite

1.
Tamayo Mariño K, Velázquez Ávila Y. Clinical-epidemiological Characterization of Patients with Chronic Actinic Damage in Las Tunas Province. Folia dermatol. cuban. [Internet]. 2022 Nov. 18 [cited 2025 Apr. 18];15(2). Available from: https://revfdc.sld.cu/index.php/fdc/article/view/171

Issue

Section

Artículo original